Skip to main content
. 2016 Jan 12;17(1):41–44. doi: 10.5152/jtgga.2015.15174

Table 1.

Studies reporting data regarding the correlation of hypodontia with ovarian cancer

First author, year, country (Ref) Publication type No. of patients Control group Incidence of hypodontia (%) No. of missing teeth Type of missing teeth (%) Distribution of hypodontia (%) Presence of ovarian cancer in family medical history (%) Isolated genes (%)
Fekonja et al. (8), 2015, Slovenia retrospective study 120 120 23/120 (19.2) NM NM Unilateral: 10/23 (43.5)
Bilateral: 13/23 (56.5)
9/23 (39) NM
Bonds et al. (9)*, 2014, USA retrospective study 95 - NM NM NM NM NM BRCA1: 7/50 (14)
EDA: 1/50 (2)
WNT10A: 6/50 (12)
AXIN2: 1/50 (2)
Fekonja et al. (10), 2014, Slovenia NRCT 120 120 23/120 (19.2) 31 maxillary SP: 14/31 (45.1)
maxillary LI: 10/31 (32.3)
mandibular SP: 5/31 (16.1)
mandibular CI: 2/31 (6.5)
Unilateral: 18/23 (78.3)
Bilateral: 5/23 (21.7)
NM NM
Chalothorn et al. (11), 2008, USA NRCT 50 100 10/50 (20) 16 maxillary LI, maxillary SP NM 3/10 (30) NM

USA: United States of America; y.o.: years old; NM: not mentioned; NRCT: non-randomized controlled trial; SP: second premolars; LI: lateral incisors; CI: central incisors; BRCA1: breast cancer 1; EDA: ectodysplasin A; WNT10A: wingless-type MMTV integration site family member 10A; AXIN2: axis inhibition protein 2

*

Refers to patients included in the Chalothorn et al. (11) study